← Leaderboards

Merrill E Gershwin

University Of California At Davis

Google Scholar ↗PubMed ↗ORCID ↗

$26,441,625

Attributed

$30,214,677

Total exposure

15

Grants

7

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.4M · FY2005–23

$2.5M$1.9M$1.3M$625K$0

'05

'06

'07

'08

'09

'10

'11

'12

'13

'14

'15

'16

'17

'18

'19

'20

'21

'22

'23

Funding mix

By agency

NIH$30,214,677 · 15

By mechanism

R01$25,317,741 · 9

R37$3,496,986 · 1

P30$553,332 · 1

R43$448,110 · 1

R21$292,833 · 1

U24$102,204 · 1

Top collaborators

Most similar at University Of California At Davis

Same institution · by research overlap

Others in their field

Top investigators on “Primary Biliary Cirrhosis”

Konstantinos N Lazaridis · Mayo Clinic Rochester$6,329,413
Gianfranco D. Alpini · Texas A&M University Health Science Ctr$5,765,914
Michael H Nathanson · Yale University$5,063,077
Burton Combes · University Of Texas Sw Med Ctr/Dallas$4,623,448
Shannon Stroud Glaser · Texas A&M University Health Science Ctr$4,370,622
Siegfried M Musser · Texas A&M University Health Science Ctr$4,001,025

Research focus

Primary Biliary CirrhosisAutoantigensMitochondriaLiverAutoantibodiesAutoimmune ProcessBaseAutoimmune DiseasesBiliaryAutoimmunityDissectionPathway InteractionsLeadLiver DiseasesCellsImmune ResponsePyruvate Dehydrogenase Complex E2ImmuneInflammationT-LymphocyteMolecularCd8b1 GeneEventClinical Research

Grant awards (77)

New Therapy for the Treatment of Primary Biliary Cholangitis.$448,110

R43 · FY2023 · DK

Mechanistically based therapeutic strategies in murine primary biliary cholangitis$389,889

R01 · FY2023 · DK · contact PI

Mechanistically based therapeutic strategies in murine primary biliary cholangitis$397,389

R01 · FY2022 · DK · contact PI

Mechanistically based therapeutic strategies in murine primary biliary cholangitis$404,589

R01 · FY2021 · DK · contact PI

Mechanistically based therapeutic strategies in murine primary biliary cholangitis$425,665

R01 · FY2020 · DK · contact PI

dnTGF Beta RII Mice and PBC$502,486

R01 · FY2017 · DK · contact PI

Xenobiotics and Primary Biliary Cirrhosis$373,932

R01 · FY2017 · DK · contact PI

dnTGF Beta RII Mice and PBC$502,072

R01 · FY2016 · DK · contact PI

Xenobiotics and Primary Biliary Cirrhosis$373,932

R01 · FY2016 · DK · contact PI

dnTGF Beta RII Mice and PBC$502,329

R01 · FY2015 · DK · contact PI

Xenobiotics and Primary Biliary Cirrhosis$373,932

R01 · FY2015 · DK · contact PI

MECHANISMS AND PATHOGENESIS OF PRIMARY BILIARY CIRRHOSIS$334,950

R01 · FY2015 · DK · contact PI

IDENTIFICATION OF COMMON AND UNCOMMON GENE VARIANTS IN PBC$526,228

R01 · FY2014 · DK

dnTGF Beta RII Mice and PBC$516,307

R01 · FY2014 · DK · contact PI

Xenobiotics and Primary Biliary Cirrhosis$373,932

R01 · FY2014 · DK · contact PI

MECHANISMS AND PATHOGENESIS OF PRIMARY BILIARY CIRRHOSIS$334,950

R01 · FY2014 · DK · contact PI

IDENTIFICATION OF COMMON AND UNCOMMON GENE VARIANTS IN PBC$617,764

R01 · FY2013 · DK

dnTGF Beta RII Mice and PBC$410,254

R01 · FY2013 · DK · contact PI

Xenobiotics and Primary Biliary Cirrhosis$373,932

R01 · FY2013 · DK · contact PI

MECHANISMS AND PATHOGENESIS OF PRIMARY BILIARY CIRRHOSIS$323,228

R01 · FY2013 · DK · contact PI

IDENTIFICATION OF COMMON AND UNCOMMON GENE VARIANTS IN PBC$626,764

R01 · FY2012 · DK

dnTGF Beta RII Mice and PBC$425,135

R01 · FY2012 · DK · contact PI

MECHANISMS AND PATHOGENESIS OF PRIMARY BILIARY CIRRHOSIS$334,679

R01 · FY2012 · DK · contact PI

XENOBIOTICS AND PRIMARY BILIARY CIRRHOSIS$284,916

R01 · FY2012 · DK · contact PI

IDENTIFICATION OF COMMON AND UNCOMMON GENE VARIANTS IN PBC$670,416

R01 · FY2011 · DK

EPIDEMIOLOGY OF PBC: A GENOME-WIDE ASSOCIATION STUDY$646,217

R01 · FY2011 · DK · contact PI

dnTGF Beta RII Mice and PBC$433,422

R01 · FY2011 · DK · contact PI

MECHANISMS AND PATHOGENESIS OF PRIMARY BILIARY CIRRHOSIS$383,438

R01 · FY2011 · DK · contact PI

XENOBIOTICS AND PRIMARY BILIARY CIRRHOSIS$284,916

R01 · FY2011 · DK · contact PI

EPIDEMIOLOGY OF PBC: A GENOME-WIDE ASSOCIATION STUDY$672,325

R01 · FY2010 · DK · contact PI

dnTGF Beta RII Mice and PBC$551,093

R01 · FY2010 · DK · contact PI

THE PATHOGENESIS OF AUTOIMMUNITY IN A MURINE MODEL OF PRIMARY BILIARY CIRRHOSIS$534,444

R01 · FY2010 · DK · contact PI

MECHANISMS AND PATHOGENESIS OF PRIMARY BILIARY CIRRHOSIS$357,984

R37 · FY2010 · DK · contact PI

XENOBIOTICS AND PRIMARY BILIARY CIRRHOSIS$287,794

R01 · FY2010 · DK · contact PI

EPIDEMIOLOGY OF PBC: A GENOME-WIDE ASSOCIATION STUDY$679,115

R01 · FY2009 · DK · contact PI

THE PATHOGENESIS OF AUTOIMMUNITY IN A MURINE MODEL OF PRIMARY BILIARY CIRRHOSIS$539,843

R01 · FY2009 · DK · contact PI

MECHANISMS AND PATHOGENESIS OF PRIMARY BILIARY CIRRHOSIS$361,600

R37 · FY2009 · DK · contact PI

XENOBIOTICS AND PRIMARY BILIARY CIRRHOSIS$290,700

R01 · FY2009 · DK · contact PI

XENOBIOTICS AND PRIMARY BILIARY CIRRHOSIS$99,999

R01 · FY2009 · DK · contact PI

EPIDEMIOLOGY OF PBC: A GENOME-WIDE ASSOCIATION STUDY$679,115

R01 · FY2008 · DK · contact PI

THE PATHOGENESIS OF AUTOIMMUNITY IN A MURINE MODEL OF PRIMARY BILIARY CIRRHOSIS$539,843

R01 · FY2008 · DK · contact PI

MECHANISMS AND PATHOGENESIS OF PRIMARY BILIARY CIRRHOSIS$361,600

R37 · FY2008 · DK · contact PI

XENOBIOTICS AND PRIMARY BILIARY CIRRHOSIS$290,700

R01 · FY2008 · DK · contact PI

EPIDEMIOLOGY OF PBC: A GENOME-WIDE ASSOCIATION STUDY$704,936

R01 · FY2007 · DK · contact PI

THE PATHOGENESIS OF AUTOIMMUNITY IN A MURINE MODEL OF PRIMARY BILIARY CIRRHOSIS$550,587

R01 · FY2007 · DK · contact PI

MECHANISMS AND PATHOGENESIS OF PRIMARY BILIARY CIRRHOSIS$368,677

R37 · FY2007 · DK · contact PI

THE PATHOGENESIS OF AUTOIMMUNITY IN A MURINE MODEL OF PRIMARY BILIARY CIRRHOSIS$591,940

R01 · FY2006 · DK · contact PI

MECHANISMS AND PATHOGENESIS OF PRIMARY BILIARY CIRRHOSIS$378,750

R37 · FY2006 · DK · contact PI

XENOBIOTICS AND PRIMARY BILIARY CIRRHOSIS$224,767

R01 · FY2006 · DK · contact PI

MECHANISMS AND PATHOGENESIS OF PRIMARY BILIARY CIRRHOSIS$334,125

R37 · FY2005 · DK

XENOBIOTICS AND PRIMARY BILIARY CIRRHOSIS$230,176

R01 · FY2005 · DK

EPIDEMIOLOGY OF PRIMARY BILIARY CIRRHOSIS$440,338

R01 · FY2004 · DK

BORAGE OIL AND GINKGO BILOBA (EGb 761) IN ASTHMA$413,143

R01 · FY2004 · AT

MECHANISMS AND PATHOGENESIS OF PRIMARY BILIARY CIRRHOSIS$334,125

R37 · FY2004 · DK

XENOBIOTICS AND PRIMARY BILIARY CIRRHOSIS$230,176

R01 · FY2004 · DK

BORAGE OIL AND GINKGO BILOBA (EGB 761) IN ASTHMA$3,471

P51 · FY2004 · RR

EPIDEMIOLOGY OF PRIMARY BILIARY CIRRHOSIS$577,246

R01 · FY2003 · DK

BORAGE OIL AND GINKGO BILOBA (EGb 761) IN ASTHMA$411,685

R01 · FY2003 · AT

MECHANISMS AND PATHOGENESIS OF PRIMARY BILIARY CIRRHOSIS$334,125

R37 · FY2003 · DK

XENOBIOTICS AND PRIMARY BILIARY CIRRHOSIS$283,635

R01 · FY2003 · DK

EPIDEMIOLOGY OF PRIMARY BILIARY CIRRHOSIS$560,431

R01 · FY2002 · DK

BORAGE OIL AND GINKGO BILOBA (EGb 761) IN ASTHMA$401,747

R01 · FY2002 · AT

MECHANISMS AND PATHOGENESIS OF PRIMARY BILIARY CIRRHOSIS$333,844

R37 · FY2002 · DK

CORE--INFLAMMATION AND IMMUNITY$0

P30 · FY2002 · DK

EPIDEMIOLOGY OF PRIMARY BILIARY CIRRHOSIS$542,676

R01 · FY2001 · DK

BORAGE OIL AND GINKGO BILOBA (EGb 761) IN ASTHMA$391,029

R01 · FY2001 · AT

MECHANISMS AND PATHOGENESIS OF PRIMARY BILIARY CIRRHOSIS$332,156

R37 · FY2001 · DK

CORE--INFLAMMATION AND IMMUNITY$276,666

P30 · FY2001 · DK

XENOBIOTICS AND PRIMARY BILIARY CIRRHOSIS$146,750

R21 · FY2001 · ES

CORE--INFLAMMATION AND IMMUNITY$0

P30 · FY2001 · DK

EPIDEMIOLOGY OF PRIMARY BILIARY CIRRHOSIS$534,493

R01 · FY2000 · DK

BORAGE OIL AND GINKGO BILOBA (EGb 761) IN ASTHMA$384,062

R01 · FY2000 · AT

MECHANISMS AND PATHOGENESIS OF PRIMARY BILIARY CIRRHOSIS$314,364

R01 · FY2000 · DK

CORE--INFLAMMATION AND IMMUNITY$276,666

P30 · FY2000 · DK

PATHOGENESIS OF AUTOIMMUNITY IN NEW ZEALAND MICE$217,676

R01 · FY2000 · AR

XENOBIOTICS AND PRIMARY BILIARY CIRRHOSIS$146,083

R21 · FY2000 · ES

ASTHMA--ALTERNATIVE MEDICINE CENTER$102,204

U24 · FY2000 · AI